MedTrace Logo

Retrospective Study to Describe the Real-world Treatment Patterns and Associated Clinical Outcomes in Patients With Metastatic Castration-resistant Prostates Cancer

NCT04801186 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1920

Last updated 2023-09-07

No results posted yet for this study

Summary

This is a multi-country, multi-centre, retrospective, non-interventional cohort study planned to include patients diagnosed with mCRPC between 01 January 2016 and 31 December 2018, who have received at least 1 line of treatment (LOT) in the mCRPC setting, and have 12 months of follow-up data available.

Conditions

  • Metastatic Castration-resistant Prostates Cancer

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-28
Primary Completion
2022-09-30
Completion
2022-09-30

Countries

  • Colombia
  • Egypt
  • India
  • Peru
  • Saudi Arabia
  • South Korea
  • Turkey (Türkiye)
  • United Arab Emirates

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04801186 on ClinicalTrials.gov